220 related articles for article (PubMed ID: 27292183)
1. Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations.
Martinez-Cruzado L; Tornin J; Santos L; Rodriguez A; García-Castro J; Morís F; Rodriguez R
Sci Rep; 2016 Jun; 6():27878. PubMed ID: 27292183
[TBL] [Abstract][Full Text] [Related]
2. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.
Li D; Zhang T; Gu W; Li P; Cheng X; Tong T; Wang W
Oncol Rep; 2015 May; 33(5):2291-8. PubMed ID: 25760144
[TBL] [Abstract][Full Text] [Related]
3. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
Mihatsch J; Toulany M; Bareiss PM; Grimm S; Lengerke C; Kehlbach R; Rodemann HP
Radiother Oncol; 2011 Jun; 99(3):300-6. PubMed ID: 21704411
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde Dehydrogenase 1 (ALDH1) Is a Potential Marker for Cancer Stem Cells in Embryonal Rhabdomyosarcoma.
Nakahata K; Uehara S; Nishikawa S; Kawatsu M; Zenitani M; Oue T; Okuyama H
PLoS One; 2015; 10(4):e0125454. PubMed ID: 25915760
[TBL] [Abstract][Full Text] [Related]
5. All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells.
Young MJ; Wu YH; Chiu WT; Weng TY; Huang YF; Chou CY
Carcinogenesis; 2015 Apr; 36(4):498-507. PubMed ID: 25742746
[TBL] [Abstract][Full Text] [Related]
6. Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line.
Ueda K; Ogasawara S; Akiba J; Nakayama M; Todoroki K; Ueda K; Sanada S; Suekane S; Noguchi M; Matsuoka K; Yano H
PLoS One; 2013; 8(10):e75463. PubMed ID: 24116047
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.
Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N
J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744
[TBL] [Abstract][Full Text] [Related]
8. High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcoma.
Emori M; Tsukahara T; Murase M; Kano M; Murata K; Takahashi A; Kubo T; Asanuma H; Yasuda K; Kochin V; Kaya M; Nagoya S; Nishio J; Iwasaki H; Sonoda T; Hasegawa T; Torigoe T; Wada T; Yamashita T; Sato N
PLoS One; 2013; 8(12):e84187. PubMed ID: 24376795
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma.
Lohberger B; Rinner B; Stuendl N; Absenger M; Liegl-Atzwanger B; Walzer SM; Windhager R; Leithner A
PLoS One; 2012; 7(8):e43664. PubMed ID: 22928012
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance.
Honoki K; Fujii H; Kubo A; Kido A; Mori T; Tanaka Y; Tsujiuchi T
Oncol Rep; 2010 Aug; 24(2):501-5. PubMed ID: 20596639
[TBL] [Abstract][Full Text] [Related]
11. ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.
Charafe-Jauffret E; Ginestier C; Bertucci F; Cabaud O; Wicinski J; Finetti P; Josselin E; Adelaide J; Nguyen TT; Monville F; Jacquemier J; Thomassin-Piana J; Pinna G; Jalaguier A; Lambaudie E; Houvenaeghel G; Xerri L; Harel-Bellan A; Chaffanet M; Viens P; Birnbaum D
Cancer Res; 2013 Dec; 73(24):7290-300. PubMed ID: 24142344
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma.
Tornin J; Martinez-Cruzado L; Santos L; Rodriguez A; Núñez LE; Oro P; Hermosilla MA; Allonca E; Fernández-García MT; Astudillo A; Suarez C; Morís F; Rodriguez R
Oncotarget; 2016 May; 7(21):30935-50. PubMed ID: 27105533
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde Dehydrogenase 1 (ALDH1) Promotes the Toxicity of TRAIL in Non-Small Cell Lung Cancer Cells via Post-Transcriptional Regulation of MEK-1 Expression.
Tian S; Liu DH; Wang D; Ren F; Xia P
Cell Physiol Biochem; 2018; 51(1):217-227. PubMed ID: 30448845
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice.
Skoda J; Nunukova A; Loja T; Zambo I; Neradil J; Mudry P; Zitterbart K; Hermanova M; Hampl A; Sterba J; Veselska R
Tumour Biol; 2016 Jul; 37(7):9535-48. PubMed ID: 26790443
[TBL] [Abstract][Full Text] [Related]
15. GRIK2 has a role in the maintenance of urothelial carcinoma stem-like cells, and its expression is associated with poorer prognosis.
Inoue R; Hirohashi Y; Kitamura H; Nishida S; Murai A; Takaya A; Yamamoto E; Matsuki M; Tanaka T; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Sato N; Masumori N; Torigoe T
Oncotarget; 2017 Apr; 8(17):28826-28839. PubMed ID: 28418868
[TBL] [Abstract][Full Text] [Related]
16. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
17. Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma.
Yue L; Huang ZM; Fong S; Leong S; Jakowatz JG; Charruyer-Reinwald A; Wei M; Ghadially R
Melanoma Res; 2015 Apr; 25(2):138-48. PubMed ID: 25643237
[TBL] [Abstract][Full Text] [Related]
18. High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis.
Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Kobayashi J; Sasaki T; Fujino J; Asanuma H; Tamura Y; Nakamori K; Hasegawa T; Hiratsuka H; Sato N
Pathol Int; 2012 Oct; 62(10):684-9. PubMed ID: 23005595
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells in sarcomas: Getting to the stemness core.
Skoda J; Veselska R
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2134-2139. PubMed ID: 30003939
[TBL] [Abstract][Full Text] [Related]
20. Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma.
Canter RJ; Ames E; Mac S; Grossenbacher SK; Chen M; Li CS; Borys D; Smith RC; Tellez J; Sayers TJ; Monjazeb AM; Murphy WJ
BMC Cancer; 2014 Oct; 14():756. PubMed ID: 25301268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
